Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer

Otolaryngology - Head and Neck Surgery (United States)

Volumn 148, Issue 5, 2013, Pages 746-752

  Dingle, Isaac F ^a   Mishoe, Ashley E ^b   Nguyen, Shaun A ^c   Overton, Lewis J ^c   Gillespie, M Boyd ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer; Quality of life; Salivary endoscopy; Sialadenitis; Thyroid; Xerostomia

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; CAFFEINE; DIURETIC AGENT; NEUROLEPTIC AGENT; RADIOACTIVE IODINE; STEROID; SUGAR; WATER;

ADULT; ANTIBIOTIC THERAPY; CANCER PATIENT; CANCER SURVIVOR; CANCER THERAPY; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; M D ANDERSON DYSPHAGIA INVENTORY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAPILLARY CARCINOMA; PATHOLOGIST; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SALIVARY GLAND; SIALOADENITIS; SMOKING; SOCIAL INTERACTION; STEROID THERAPY; SWALLOWING; UNIVERSITY OF WASHINGTON QUALITY OF LIFE QUESTIONNAIRE; XEROSTOMIA; XEROSTOMIA RELATED QUALITY OF LIFE SCALE; ADOLESCENT; AGED; ARTICLE; DYSPHAGIA; MIDDLE AGED; THYROID TUMOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEGLUTITION DISORDERS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SIALADENITIS; THYROID NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879285043     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813479777     Document Type: Conference Paper

References (16)

1. Brown RL, de Souza JA, Cohen EE. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011;2:193-199.
2. Mazzaferri EL. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma. Thyroid. 1997;7:265-271.
3. Jensen SB, Pedersen AM, Vissinik A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039-1060.
4. Limesand KH, Said S, Anderson SM. Suppression of radiation-induced salivary gland dysfunction by IGF-1. PLoS ONE. 2009;4(3):e4663. doi:10.1371/journal.pone.0004663.
5. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199-212.
6. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001;127:870-876.
7. Hassan SJ, Waymuller EA. Assessment of quality of life in head and neck cancer patients. Head Neck. 1993;6:485-496.
8. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37:84-93.
9. Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998;39: 1551-1554.
10. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25:755-758.
11. Almeida JP, Sanabria AE, Lima EN, Kowalski LP. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck. 2011;33:686-690.
12. Hyer S, Kong A, Pratt B, Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol). 2007;19:83-86.
13. Van Nostrand D. Sialoadenitis secondary to I-131 therapy for well-differentiated thyroid cancer. Oral Dis. 2011;17:154-161.
14. Almeida JP, Vartanian JG, Kowalski LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg. 2009;135:342-346.
15. Bomeli SR, Schaitkin B, Carrau RL, Walvekar RR. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis. Laryngoscope. 2009;119:564-567.
16. Prendes BL, Orloff LA, Eisele DW. Therapeutic sialendoscopy for the management of radioiodine sialadenitis. Arch Otolaryngol Head Neck Surg. 2012;128:15-19.